UY27569A1 - COMBINATION OF A FORM OF CRYSTAL DRUG AND A TIOTROPIO SALT - Google Patents

COMBINATION OF A FORM OF CRYSTAL DRUG AND A TIOTROPIO SALT

Info

Publication number
UY27569A1
UY27569A1 UY27569A UY27569A UY27569A1 UY 27569 A1 UY27569 A1 UY 27569A1 UY 27569 A UY27569 A UY 27569A UY 27569 A UY27569 A UY 27569A UY 27569 A1 UY27569 A1 UY 27569A1
Authority
UY
Uruguay
Prior art keywords
combination
salt
tiotropio
crystal drug
ethyl
Prior art date
Application number
UY27569A
Other languages
Spanish (es)
Inventor
Terence V Silk
Julian D Smith
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to UY27569A priority Critical patent/UY27569A1/en
Publication of UY27569A1 publication Critical patent/UY27569A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una combinación de una forma cristalina de 6-((2,2-difenitel)amino)-9-(N-5 etil-B-D-ribofuranosiluronamida)-N-(2-(N'-(1-(2-piridil)-4-piperidil)ureido)etil)-9H-purin-2-carboxamida y una sal de tiotropio. Tal combinación es útil en el tratamiento de enfermedades respiratorias tales como enfermedad pulmonar obstructiva crónica.The present invention relates to a combination of a crystalline form of 6 - ((2,2-diphenyle) amino) -9- (N-5-ethyl-BD-ribofuranosyluronamide) -N- (2- (N '- (1 - (2-Pyridyl) -4-piperidyl) ureido) ethyl) -9H-purin-2-carboxamide and a tiotropium salt. Such a combination is useful in the treatment of respiratory diseases such as chronic obstructive pulmonary disease.

UY27569A 2002-12-05 2002-12-05 COMBINATION OF A FORM OF CRYSTAL DRUG AND A TIOTROPIO SALT UY27569A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27569A UY27569A1 (en) 2002-12-05 2002-12-05 COMBINATION OF A FORM OF CRYSTAL DRUG AND A TIOTROPIO SALT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27569A UY27569A1 (en) 2002-12-05 2002-12-05 COMBINATION OF A FORM OF CRYSTAL DRUG AND A TIOTROPIO SALT

Publications (1)

Publication Number Publication Date
UY27569A1 true UY27569A1 (en) 2003-07-31

Family

ID=38812720

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27569A UY27569A1 (en) 2002-12-05 2002-12-05 COMBINATION OF A FORM OF CRYSTAL DRUG AND A TIOTROPIO SALT

Country Status (1)

Country Link
UY (1) UY27569A1 (en)

Similar Documents

Publication Publication Date Title
WO2004045618A3 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
IL190150A0 (en) New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
CY1110676T1 (en) PYRAZOLO [3,4-b] Pyridine compounds, and their use as phosphodiesterase inhibitors
EP1965823A4 (en) METHODS OF ADMINISTERING HYPOGLYCEMIC AGENTS
ATE530530T1 (en) DIAMINOPYRIMIDINE CARBONIC ACID AMIDE DERIVATIVE
NO20065878L (en) Therapeutic compounds
NZ618277A (en) Uracil or thymine derivative for treating hepatitis c
TNSN04165A1 (en) Substituted hydroxyethylamines
MX2007003321A (en) Heterocyclic derivatives and their use as therapeutic agents.
NO20076418L (en) Heterocyclic compounds as agonists for the thyroid receptor
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
NZ590839A (en) Treatment of pulmonary arterial hypertension
NO20083032L (en) Use of benzofused heterocyclic sulfamide derivatives for the treatment of mania and bipolar disorder
MX2007000028A (en) Nicotinamide derivatives and their use as therapeutic agents.
MY157949A (en) Thioxanthine derivatives as myeloperoxidase inhibitors
BR0309185A (en) Beta-mimetic drug and a new anticholinergic
BRPI0415636A (en) crystalline anhydrate with anticholinergic effect
AR037633A1 (en) COMBINATION OF A FORM OF CRYSTAL FARMACO AND A TIOTROPIO SALT
RS20060293A (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
EP1896433A4 (en) Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
UY27569A1 (en) COMBINATION OF A FORM OF CRYSTAL DRUG AND A TIOTROPIO SALT
ATE547104T1 (en) COMPOSITION CONTAINING A LUNG SURFACTANT AND SILDENAFIL FOR THE TREATMENT OF LUNG DISEASES
NI200700039A (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS.
DOP2002000526A (en) COMBINATION OF A FORM OF CRYSTAL FARMACO AND A TIOTROPIO SALT.
WO2006045314A3 (en) Use of a growth hormone secretatogue for increasing or maintaining lean body mass and/or for treatment of chronic obstructive pulmonary disease

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126